Search Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupLymphomas (ped.)DiseaseHodgkin LymphomaSubgroupICD10C81.-MeSHSequencePAED EuroNet-PHL-C2, Hodgkin, TL-1PAED EuroNet-PHL-C2, Hodgkin, TL-2PAED EuroNet-PHL-C2, Hodgkin, TL-3ChemotherapyChemo-substanceCyclophosphamideDacarbazineDoxorubicinEtoposidePrednisoloneVincristineChemo-substanceCyclophosphamideDacarbazineDoxorubicinEtoposidePrednisoloneVincristineChemo-substanceCyclophosphamideDacarbazineDoxorubicinEtoposidePrednisoloneVincristineChemo-substanceCyclophosphamideDacarbazineDoxorubicinEtoposidePrednisoloneVincristineNo. Substances46 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCotrimoxazoleFosaprepitantGranisetronMesnaSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleFosaprepitantGranisetronMesnaSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleFosaprepitantGranisetronMesnaSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleFosaprepitantGranisetronMesnaNo. Substances5Protocol classificationTherapy classificationStudy protocol, currentIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorKörholz DDiseaseNeudiagnostiziertes Hodgkin Lymphom im Kindes- und JugendalterOriginEuropean Network-Paediatric Hodgkin’s Lymphoma Study Group (EuroNet-PHL)Protocols in Revision 2 protocols foundProtocols under revision.PAED EuroNet-PHL-C2, COPDAC-28, Hodgkin Lymphoma (PID1279 V1.0)PAED EuroNet-PHL-C2, DECOPDAC-21, Hodgkin Lymphoma (PID1239 V1.0)
